BioSpace News Archive

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the third quarter ended September 30, 2020 and provided a company update. “We made great progress toward our strategic and operational objectives during the third quarter. I’m proud to report that despite this year’s challenging operating environment, our team continued to execute efficiently, allowing us to maintain our progress towar

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executive Officer, and Brian Posner, Chief Financial Officer, will participate in two upcoming investor conferences: Sidoti Virtual Microcap Conference 2020 Format: corporate presentation followed by 1x1 virtual investor meetings Date: Thursday, November 19 Time: 10:45am – 11:45am ET Investors can register fo

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive Officer, will present via webcast at the 2020 Jefferies London Healthcare Conference on November 19 at 12 p.m. EST. The Company will also be participating in the virtual Piper Sandler 32nd Annual Healthcare Conference being held December 1-3. A live audio webcast of the

MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, MiMedx Chief Executive Officer, and Peter M. Carlson, MiMedx Chief Financial Officer, will present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020, beginning at 9:30 am, Eastern Time. A live webcast of the presentatio

Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will host a virtual Investor Day on November 20, 2020 at 8AM EST/ 1PM GMT.

The American Cancer Society held their 2020 Taste of Hope, an annual event that brings award-winning chefs and Chicago foodies together, to celebrate the charity’s fight against cancer.

AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Thursday, November 19, 2020. Michael Severino, M.D., vice chairman and president, and Robert A. Michael, executive vice president and chief financial officer, will present at 11:35 a.m. Central time.

TYME revealed potential new oral therapy, TYME-19, in the fight against COVID-19 based on its cancer metabolism research program

Ken Keller Appointed as Head of the Oncology Business Unit Overseeing Global Oncology Strategy and U.S. and European Oncology Businesses

Trefoil Therapeutics, which is developing first-in-class regenerative treatments for corneal diseases, announced today it has received the ‘People’s Choice’ award at the inaugural Eyecelerator virtual conference. The company’s lead product, an engineered fibroblast growth factor 1 (FGF-1, TTHX1114) administered by intracameral (behind the cornea) injection, recently entered a Phase 1/2 clinical trial for the treatment of endot